Multiple Sclerosis (MS) Support Group

This community is a place where members can discuss current events and weigh in on what's going on in the world.

0 Online

deleted_user 01/22/2010

Fampridine-SR, also known as Amaya was approved today by the FDA to improve walking speed in RR,SP,PP,PR MS. To be taken with a CRAB drug or something to slow the progression also. Amaya is a symptom treatment to improve walking in all forms of MS.

http://www.dailystrength.org/c/Multiple_Sclerosis_MS/forum/8208713-amaya-walking-speed

http://www.startribune.com/business/82418377.html

http://www.cnn.com/2010/HEALTH/01/22/fda.approval.ms.drug/index.html?section=cnn_latest

http://www.redorbit.com/news/health/1812898/fda_approves_ampyra_to_improve_walking_in_adults_with_multiple/index.html?source=r_health

http://news.yahoo.com/s/usnw/20100122/pl_usnw/DC42547_1;_ylc=X3oDMTB0ZDZkY2k4BF9TAzIxNTExMDUEZW1haWxJZAMxMjY0MjExMjkw

http://www.bloomberg.com/apps/news?pid=20601103&sid=ag8U6KGYO4vQ

deleted_user 01/22/2010

I hope I got these names tied right...that fampridine-sr has gone through so many name changes...in the CNN article it says...

The FDA says the drug, Ampyra (generic name dalfampridine, formerly known as fampridine), is the first MS therapy that is taken orally and the first of its kind to receive FDA approval. It is designed help people with any type of MS improve their walking speed.

deleted_user 01/22/2010

Here is another article that directly call ampyra

Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004

FDA Approves Fampridine SR, Now Called Ampyra, to Improve Walking for People With All Types of Multiple Sclerosis

NEW YORK, Jan. 22 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration has approved the marketing of Ampyra (dalfampridine, formerly known as fampridine SR, from Acorda Therapeutics) for its ability to improve walking speed in people with any type of multiple sclerosis.

http://finance.boston.com/boston/?GUID=11591446&Page=MEDIAVIEWER

The name of that drug has made it tremendously difficult to follow!

deleted_user 01/22/2010

More Articles on it.....

http://abcnews.go.com/Business/wireStory?id=9637831

http://www.iii.co.uk/news/?type=afxnews&articleid=7720629&subject=economic&action=article

http://www.nasdaq.com/aspx/stock-market-news-story.aspx?storyid=201001221612dowjonesdjonline000615&title=fda-oks-ampyra-to-improve-walking-in-adults-with-multiple-sclerosis
************
FDA ANNOUNCEMENT OF APPROVAL

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm198463.htm

*************************************************************************

http://www.bloomberg.com/apps/news?pid=20601202&sid=aUF84TpH7dVU

deleted_user 01/22/2010

Thanks for the info. I have to set aside at least an hour when I see a new post from you!

deleted_user 01/23/2010

Another one...Its Ampyra...I miss spelled it in, but the name has changed so often....
http://www.physorg.com/news183437559.html

I believe Nikki, that has some kind of name for the 22nd century, that we have too much choice now. I can't remember what they call it. Microsoft has that search engine they are advertising, I can't think of that name either, something about information overload.

deleted_user 01/23/2010

21st Century, I think it started in the 20th Century. I got ahead of myself writing the 22nd century. You might be operating on 19th century principles, where it was easier to select and digest info because there was less of it available :)

deleted_user 01/23/2010

NMS link on it...

http://www.nationalmssociety.org/news/news-detail/index.aspx?nid=2586

deleted_user 01/23/2010

Link to a thread posted on general board...the name changes have been excessive in this drug.

http://www.dailystrength.org/c/Multiple_Sclerosis_MS/forum/8928366-ampyra

Join the Conversation